$NXDT
NEXPOINT DIVERSIFIED REAL ESTATE TRUST Stock $nxdt

$nxdt Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000135611524000007 Filed on March 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$12.81M	$22.17M	$63.28M
YoY Change	-13.86%	-59.78%	-52.89%
Cost Of Revenue	$3.422M	$2.965M	$13.67M
YoY Change	-12.53%	-60.07%	-26.41%
Gross Profit	$9.383M	$19.21M	$49.62M
YoY Change	-14.34%	-59.73%	-57.14%
Gross Profit Margin	73.28%	86.63%	78.4%
Selling, General & Admin	$4.741M	$4.517M	$16.61M
YoY Change	31.84%	-25.66%	165.26%
% of Gross Profit	50.53%	23.52%	33.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.796M	$3.037M	$13.94M
YoY Change	-20.66%	-14.01%	94.24%
% of Gross Profit	29.8%	15.81%	28.09%
Operating Expenses	$9.114M	$9.462M	$38.03M
YoY Change	5.66%	-44.12%	116.4%
Operating Profit	$269.0K	$9.747M	$11.58M
YoY Change	-88.45%	-68.33%	-88.2%
Interest Expense	$4.531M	-$24.36M	$15.90M
YoY Change	30.88%	-76.21%	-139.14%
% of Operating Profit	1684.39%	-249.87%	137.31%
Other Income/Expense, Net
YoY Change
Pretax Income	-$21.00M	-$14.61M	-$114.5M
YoY Change	12.2%	-79.6%	-298.99%
Income Tax	$550.0K	$1.287M	$2.731M
% Of Pretax Income
Net Earnings	-$21.55M	-$17.05M	-$117.2M
YoY Change	10.38%	-79.68%	-372.96%
Net Earnings / Revenue	-168.28%	-76.89%	-185.26%
Basic Earnings Per Share	-$0.59		-$3.26
Diluted Earnings Per Share	-$0.59	-$0.45	-$3.26
COMMON SHARES
Basic Shares Outstanding	38.56M shares	37.81M shares	37.33M shares
Diluted Shares Outstanding	38.57M shares		37.33M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$689.7M	$711.8M	$20.61M
YoY Change	-6.32%	-7.34%	53.79%
Cash & Equivalents	$20.17M	$20.61M	$20.61M
Short-Term Investments	$669.5M	$691.2M
Other Short-Term Assets	$12.59M	$10.43M	$10.43M
YoY Change	153.96%	61.95%	62.98%
Inventory
Prepaid Expenses
Receivables	$9.880M	$10.43M	$10.43M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$42.65M	$41.46M	$41.46M
YoY Change	107.85%	59.44%	59.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$262.4M	$263.9M	$263.9M
YoY Change	-2.01%	-0.82%	-0.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$63.53M	$66.26M	$757.5M
YoY Change	-9.05%	-6.22%	-8.25%
Other Assets	$36.42M	$35.46M	$35.46M
YoY Change	-6.17%	-5.54%	-5.45%
Total Long-Term Assets	$1.032B	$1.057B	$1.057B
YoY Change	-11.86%	-11.7%	-11.7%
TOTAL ASSETS
Total Short-Term Assets	$42.65M	$41.46M	$41.46M
Total Long-Term Assets	$1.032B	$1.057B	$1.057B
Total Assets	$1.075B	$1.098B	$1.098B
YoY Change	-9.8%	-10.19%	-10.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.090M	$8.633M	$8.633M
YoY Change	-43.33%	-37.74%	-37.89%
Accrued Expenses	$2.392M	$1.629M	$1.629M
YoY Change	5.89%	18.99%	16.36%
Deferred Revenue
YoY Change
Short-Term Debt	$415.0K	$422.0K	$422.0K
YoY Change	-1.66%	1.44%	5.5%
Long-Term Debt Due	$0.00	$29.00M	$29.00M
YoY Change	-100.0%		163.64%
Total Short-Term Liabilities	$12.14M	$40.81M	$40.81M
YoY Change	-66.36%	47.03%	5.18%
LONG-TERM LIABILITIES
Long-Term Debt	$195.1M	$167.9M	$167.9M
YoY Change	23.56%	-1.99%	4.73%
Other Long-Term Liabilities	$4.274M	$0.00	$4.567M
YoY Change	-24.43%	-100.0%	-23.88%
Total Long-Term Liabilities	$199.4M	$0.00	$172.5M
YoY Change	21.9%	-100.0%	3.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.14M	$40.81M	$40.81M
Total Long-Term Liabilities	$199.4M	$0.00	$172.5M
Total Liabilities	$211.5M	$213.3M	$213.3M
YoY Change	5.95%	3.99%	3.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$155.2M	-$126.6M
YoY Change	1768.44%	-805.3%
Common Stock	$39.00K	$38.00K
YoY Change	5.41%	2.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$863.0M	$885.1M	$885.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.075B	$1.098B	$1.098B
YoY Change	-9.8%	-10.19%	-10.19%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$21.55M	-$17.05M	-$117.2M
YoY Change	10.38%	-79.68%	-372.96%
Depreciation, Depletion And Amortization	$2.796M	$3.037M	$13.94M
YoY Change	-20.66%	-14.01%	94.24%
Cash From Operating Activities	-$2.555M	-$5.766M	-$24.27M
YoY Change	-605.94%	-466.79%	-135.81%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$7.436M	$5.990M	$21.99M
YoY Change	-9.69%	-143.26%	-181.39%
Cash From Investing Activities	$7.436M	$5.990M	$21.99M
YoY Change	-9.69%	-143.26%	-181.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$4.361M	15.10M	$6.796M
YoY Change	-65.35%	-192.18%	-112.56%
NET CHANGE
Cash From Operating Activities	-$2.555M	-5.766M	-$24.27M
Cash From Investing Activities	$7.436M	5.990M	$21.99M
Cash From Financing Activities	-$4.361M	15.10M	$6.796M
Net Change In Cash	$520.0K	15.32M	$4.520M
YoY Change	-113.51%	-153.47%	-133.83%
FREE CASH FLOW
Cash From Operating Activities	-$2.555M	-$5.766M	-$24.27M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-32921
CY2023	dei	Entity Registrant Name EntityRegistrantName	NexPoint Diversified Real Estate Trust
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	80-0139099
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	300 Crescent Court
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2023	dei	City Area Code CityAreaCode	214
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	0.68750
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	29146000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	32594000	usd
	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	11139000	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	11139000	usd
CY2021Q4	nxdt	Investment Company Net Assets InvestmentCompanyNetAssets	911208000	usd
CY2022Q2	nxdt	Investment Company Net Assets InvestmentCompanyNetAssets	1029616000	usd
CY2023	nxdt	Increase Decrease In Deferred Tax Asset IncreaseDecreaseInDeferredTaxAsset	-648000	usd
CY2023	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	9077000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4923000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24266000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001356115
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75201
CY2023	dei	Local Phone Number LocalPhoneNumber	276-6300
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	378106596	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38559520.61	shares
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023	dei	Auditor Name AuditorName	KPMG, LLP
CY2023	dei	Auditor Location AuditorLocation	Dallas, Texas, United States
CY2023Q4	us-gaap	Land Land	47708000	usd
CY2022Q4	us-gaap	Land Land	47708000	usd
CY2023Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	206213000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	174469000	usd
CY2023Q4	us-gaap	Rental Properties RentalProperties	10979000	usd
CY2022Q4	us-gaap	Rental Properties RentalProperties	10979000	usd
CY2023Q4	us-gaap	Development In Process DevelopmentInProcess	19177000	usd
CY2022Q4	us-gaap	Development In Process DevelopmentInProcess	39731000	usd
CY2023Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	362000	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	354000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	284439000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	273241000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	20525000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	7158000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	263914000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	266083000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	754910000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	70656000	usd
CY2023Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	0	usd
CY2022Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	67711000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20608000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	32561000	usd
CY2023Q4	us-gaap	Receivables From Customers ReceivablesFromCustomers	4347000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	10431000	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	6078000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2896000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2247000	usd
CY2023Q4	us-gaap	Assets Assets	1098336000	usd
CY2022Q4	us-gaap	Assets Assets	1222902000	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	142186000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	144414000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	52919000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	24250000	usd
CY2023Q4	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	1782000	usd
CY2022Q4	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	2624000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	8633000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	13865000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	356000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10720000	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	231000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	254000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1398000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1115000	usd
CY2023Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	422000	usd
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	416000	usd
CY2023Q4	us-gaap	Advance Rent AdvanceRent	768000	usd
CY2022Q4	us-gaap	Advance Rent AdvanceRent	1273000	usd
CY2023Q4	nxdt	Intangible Lease Liabilities Net IntangibleLeaseLiabilitiesNet	4567000	usd
CY2022Q4	nxdt	Intangible Lease Liabilities Net IntangibleLeaseLiabilitiesNet	6027000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	112000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	213262000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	205070000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4800000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4800000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3359593	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3359593	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3359593	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	3000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	3000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38389600	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38389600	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37171807	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37171807	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	38000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	37000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1011613000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	999845000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126580000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17947000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	885074000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1017832000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1098336000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1222902000	usd
CY2023	us-gaap	Lease Income LeaseIncome	20309000	usd
	us-gaap	Lease Income LeaseIncome	10070000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	7029000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4428000	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	35638000	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	40600000	usd
CY2023	us-gaap	Other Income OtherIncome	308000	usd
	us-gaap	Other Income OtherIncome	32000	usd
CY2023	us-gaap	Revenues Revenues	63284000	usd
	us-gaap	Revenues Revenues	55130000	usd
CY2023	nxdt	Property Operating Expenses PropertyOperatingExpenses	7489000	usd
	nxdt	Property Operating Expenses PropertyOperatingExpenses	3682000	usd
CY2023	us-gaap	Management Fee Expense ManagementFeeExpense	726000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	296000	usd
CY2023	us-gaap	Taxes Excluding Income And Excise Taxes TaxesExcludingIncomeAndExciseTaxes	4377000	usd
	us-gaap	Taxes Excluding Income And Excise Taxes TaxesExcludingIncomeAndExciseTaxes	2695000	usd
CY2023	nxdt	Advisory And Administrative Fees AdvisoryAndAdministrativeFees	11740000	usd
	nxdt	Advisory And Administrative Fees AdvisoryAndAdministrativeFees	5514000	usd
CY2023	nxdt	Conversion Expense ConversionExpense	1203000	usd
	nxdt	Conversion Expense ConversionExpense	1615000	usd
CY2023	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	13937000	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	7175000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	51703000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	24358000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	11581000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	30772000	usd
CY2023	us-gaap	Interest Expense InterestExpense	15902000	usd
	us-gaap	Interest Expense InterestExpense	5759000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-306000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2257000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-108249000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-92031000	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1634000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2323000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-114510000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-71598000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2731000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9975000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-117241000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-81573000	usd
CY2023	nxdt	Net Income Loss Attributable To Preferred Shareholders NetIncomeLossAttributableToPreferredShareholders	-4619000	usd
	nxdt	Net Income Loss Attributable To Preferred Shareholders NetIncomeLossAttributableToPreferredShareholders	-2310000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-121860000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-83883000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37334000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37172000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37334000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37172000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.26
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.26
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	79196000	usd
	us-gaap	Noninterest Expense Investment Advisory Fees NoninterestExpenseInvestmentAdvisoryFees	6279000	usd
	us-gaap	Investment Income Operating Tax Expense Benefit InvestmentIncomeOperatingTaxExpenseBenefit	2000000	usd
	us-gaap	Legal Fees LegalFees	987000	usd
	us-gaap	Interest Expense InterestExpense	696000	usd
	nxdt	Conversion Expense ConversionExpense	471000	usd
	us-gaap	Professional Fees ProfessionalFees	334000	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	185000	usd
	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	136000	usd
	us-gaap	Trustee Fees TrusteeFees	109000	usd
	nxdt	Audit And Tax Preparation Fees AuditAndTaxPreparationFees	77000	usd
	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	72000	usd
	nxdt	Pricing Fees PricingFees	68000	usd
	us-gaap	Investment Company Registration Expense InvestmentCompanyRegistrationExpense	56000	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	322000	usd
	nxdt	Investment Company Expense Operating After Tax InvestmentCompanyExpenseOperatingAfterTax	11792000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	67404000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2310000	usd
	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	61740000	usd
	nxdt	Period Increase Decrease In Net Assets Resulting From Operations PeriodIncreaseDecreaseInNetAssetsResultingFromOperations	126834000	usd
CY2021	nxdt	Securities Lending Income SecuritiesLendingIncome	6000	usd
CY2021	nxdt	Return Of Capital Reclassification ReturnOfCapitalReclassification	-11850000	usd
CY2021	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	95136000	usd
CY2021	us-gaap	Noninterest Expense Investment Advisory Fees NoninterestExpenseInvestmentAdvisoryFees	11094000	usd
CY2021	us-gaap	Legal Fees LegalFees	2206000	usd
CY2021	us-gaap	Interest Expense InterestExpense	2435000	usd
CY2021	nxdt	Conversion Expense ConversionExpense	1397000	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	558000	usd
CY2021	us-gaap	General Insurance Expense GeneralInsuranceExpense	145000	usd
CY2021	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	352000	usd
CY2021	us-gaap	Trustee Fees TrusteeFees	275000	usd
CY2021	nxdt	Audit And Tax Preparation Fees AuditAndTaxPreparationFees	124000	usd
CY2021	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	101000	usd
CY2021	nxdt	Pricing Fees PricingFees	279000	usd
CY2021	us-gaap	Investment Company Registration Expense InvestmentCompanyRegistrationExpense	75000	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	990000	usd
CY2021	nxdt	Investment Company Expense Operating After Tax InvestmentCompanyExpenseOperatingAfterTax	20029000	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	75107000	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4555000	usd
CY2021	us-gaap	Unrealized Gain Loss Security Sold Short Operating UnrealizedGainLossSecuritySoldShortOperating	649000	usd
CY2021	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	174903000	usd
CY2021	nxdt	Period Increase Decrease In Net Assets Resulting From Operations PeriodIncreaseDecreaseInNetAssetsResultingFromOperations	245455000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1017832000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1344000	usd
CY2023	nxdt	Shares Issued To Advisor For Admin And Advisory Fees SharesIssuedToAdvisorForAdminAndAdvisoryFees	1431000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-121860000	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-4619000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.60
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	13673000	usd
CY2023	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	1.375
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	4619000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	885074000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1112868000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-2310000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
	us-gaap	Dividends Common Stock DividendsCommonStock	11153000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2310000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1017832000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	67404000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2310000	usd
	nxdt	Investment Company Net Assets From Operations Period Increase Decrease InvestmentCompanyNetAssetsFromOperationsPeriodIncreaseDecrease	126834000	usd
	nxdt	Increase In Net Assets From Operations And Distributions IncreaseInNetAssetsFromOperationsAndDistributions	115695000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1288000	usd
	nxdt	Net Increase Decrease From Shares Transactions NetIncreaseDecreaseFromSharesTransactions	2713000	usd
	us-gaap	Investment Company Increase Decrease From Share Transaction InvestmentCompanyIncreaseDecreaseFromShareTransaction	118408000	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	75107000	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4555000	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-41721000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	216624000	usd
CY2021	nxdt	Investment Company Net Assets From Operations Period Increase Decrease InvestmentCompanyNetAssetsFromOperationsPeriodIncreaseDecrease	245455000	usd
CY2021	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	435000	usd
CY2021	us-gaap	Partners Capital Account Return Of Capital PartnersCapitalAccountReturnOfCapital	21766000	usd
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	22201000	usd
CY2021	nxdt	Increase In Net Assets From Operations And Distributions IncreaseInNetAssetsFromOperationsAndDistributions	223254000	usd
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-152321000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	47319000	usd
CY2021	nxdt	Net Increase Decrease From Shares Transactions NetIncreaseDecreaseFromSharesTransactions	-102871000	usd
CY2021	us-gaap	Investment Company Increase Decrease From Share Transaction InvestmentCompanyIncreaseDecreaseFromShareTransaction	120383000	usd
CY2020Q4	nxdt	Investment Company Net Assets InvestmentCompanyNetAssets	790825000	usd
CY2021Q4	nxdt	Investment Company Net Assets InvestmentCompanyNetAssets	911208000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-117241000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-81573000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13937000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7175000	usd
CY2023	nxdt	Amortization Of Intangible Lease Liabilities AmortizationOfIntangibleLeaseLiabilities	-1217000	usd
	nxdt	Amortization Of Intangible Lease Liabilities AmortizationOfIntangibleLeaseLiabilities	-743000	usd
CY2023	nxdt	Amortization Accretion Of Deferred Financing Costs AmortizationAccretionOfDeferredFinancingCosts	776000	usd
	nxdt	Amortization Accretion Of Deferred Financing Costs AmortizationAccretionOfDeferredFinancingCosts	67000	usd
CY2023	nxdt	Paid In Kind Interest Operating Activity PaidInKindInterestOperatingActivity	5952000	usd
	nxdt	Paid In Kind Interest Operating Activity PaidInKindInterestOperatingActivity	2872000	usd
CY2023	nxdt	Proceeds From Paid In Kind Interest On Paydowns Or Sales From Investments ProceedsFromPaidInKindInterestOnPaydownsOrSalesFromInvestments	-3730000	usd
	nxdt	Proceeds From Paid In Kind Interest On Paydowns Or Sales From Investments ProceedsFromPaidInKindInterestOnPaydownsOrSalesFromInvestments	0	usd
CY2023	nxdt	Realized Investment Gains Losses Including Noncash Amounts RealizedInvestmentGainsLossesIncludingNoncashAmounts	-1634000	usd
	nxdt	Realized Investment Gains Losses Including Noncash Amounts RealizedInvestmentGainsLossesIncludingNoncashAmounts	-2323000	usd
CY2023	nxdt	Unrealized Gain Loss On Investments Including Noncash Amounts UnrealizedGainLossOnInvestmentsIncludingNoncashAmounts	108249000	usd
	nxdt	Unrealized Gain Loss On Investments Including Noncash Amounts UnrealizedGainLossOnInvestmentsIncludingNoncashAmounts	92031000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-306000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2257000	usd
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	4087000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2418000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1344000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	nxdt	Payments For Life Settlement Premiums PaymentsForLifeSettlementPremiums	3355000	usd
	nxdt	Payments For Life Settlement Premiums PaymentsForLifeSettlementPremiums	2576000	usd
CY2023	nxdt	Equity Security Dividends Reinvested EquitySecurityDividendsReinvested	5529000	usd
	nxdt	Equity Security Dividends Reinvested EquitySecurityDividendsReinvested	0	usd
	nxdt	Increase Decrease In Deferred Tax Asset IncreaseDecreaseInDeferredTaxAsset	-2247000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-10364000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10720000	usd
CY2023	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	-23000	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	-2069000	usd
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	-606000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	5914000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31431000	usd
CY2023	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	4000000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	0	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	9170000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	18105000	usd
CY2023	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	16512000	usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	14246000	usd
CY2023	nxdt	Proceeds From Paydowns Of Investments ProceedsFromPaydownsOfInvestments	9759000	usd
	nxdt	Proceeds From Paydowns Of Investments ProceedsFromPaydownsOfInvestments	0	usd
CY2023	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	5984000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	11276000	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1382000	usd
CY2023	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	10474000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	5966000	usd
CY2023	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	0	usd
	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	26500000	usd
CY2023	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	0	usd
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	8700000	usd
CY2023	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	3000000	usd
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	7055000	usd
CY2023	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	3993000	usd
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	21990000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14418000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	39000000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	13250000	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2364000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1181000	usd
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	11919000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	9543000	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	10000000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	12500000	usd
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	12761000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	14410000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	971000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	379000	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	4619000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	2310000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13408000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	11153000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6796000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19140000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4520000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2127000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	48649000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	50776000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53169000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	48649000	usd
CY2023	nxdt	Noncash Interest Paid Received NoncashInterestPaidReceived	15619000	usd
	nxdt	Noncash Interest Paid Received NoncashInterestPaidReceived	5284000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	13737000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1501000	usd
CY2023	nxdt	Capitalized Construction Costs Included In Accounts Payable And Other Accrued Liabilities CapitalizedConstructionCostsIncludedInAccountsPayableAndOtherAccruedLiabilities	723000	usd
	nxdt	Capitalized Construction Costs Included In Accounts Payable And Other Accrued Liabilities CapitalizedConstructionCostsIncludedInAccountsPayableAndOtherAccruedLiabilities	3883000	usd
CY2023	nxdt	Fair Value Assets Acquired From The Contribution Of Equity Method Investments FairValueAssetsAcquiredFromTheContributionOfEquityMethodInvestments	0	usd
	nxdt	Fair Value Assets Acquired From The Contribution Of Equity Method Investments FairValueAssetsAcquiredFromTheContributionOfEquityMethodInvestments	62510000	usd
CY2023	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	8994000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	usd
CY2023	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	68500000	usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	usd
CY2023	nxdt	Noncash Advisory Fee Payment NoncashAdvisoryFeePayment	1431000	usd
	nxdt	Noncash Advisory Fee Payment NoncashAdvisoryFeePayment	0	usd
CY2023	nxdt	Increase In Dividends Payable Upon Vesting Of Restricted Stock Units IncreaseInDividendsPayableUponVestingOfRestrictedStockUnits	265000	usd
	nxdt	Increase In Dividends Payable Upon Vesting Of Restricted Stock Units IncreaseInDividendsPayableUponVestingOfRestrictedStockUnits	0	usd
CY2023	nxdt	Adjustment To Life Insurance Policies At Fair Value On Deconsolidation Of Entity AdjustmentToLifeInsurancePoliciesAtFairValueOnDeconsolidationOfEntity	-62484000	usd
	nxdt	Adjustment To Life Insurance Policies At Fair Value On Deconsolidation Of Entity AdjustmentToLifeInsurancePoliciesAtFairValueOnDeconsolidationOfEntity	0	usd
CY2023	nxdt	Adjustment To Accounts Receivable On Deconsolidation Of Entity AdjustmentToAccountsReceivableOnDeconsolidationOfEntity	-2023000	usd
	nxdt	Adjustment To Accounts Receivable On Deconsolidation Of Entity AdjustmentToAccountsReceivableOnDeconsolidationOfEntity	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	126834000	usd
	nxdt	Payments For Purchase Of Securities Sold Short Operating Activities PaymentsForPurchaseOfSecuritiesSoldShortOperatingActivities	177000	usd
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	171000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	28893000	usd
	us-gaap	Realized Gain Loss Security Sold Short Operating RealizedGainLossSecuritySoldShortOperating	253000	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-741000	usd
	us-gaap	Increase Decrease In Client Funds Held IncreaseDecreaseInClientFundsHeld	-192000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1583000	usd
	nxdt	Increase Decrease In Reclaim Receivable IncreaseDecreaseInReclaimReceivable	-1250000	usd
	nxdt	Increase Decrease In Foreign Tax Reclaim Receivable IncreaseDecreaseInForeignTaxReclaimReceivable	1274000	usd
	us-gaap	Increase Decrease In Payables To Broker Dealers IncreaseDecreaseInPayablesToBrokerDealers	-1695000	usd
	nxdt	Increase Decrease In Payable For Admin Fees IncreaseDecreaseInPayableForAdminFees	-11000	usd
	nxdt	Increase Decrease In Payables For Audit Fees IncreaseDecreaseInPayablesForAuditFees	49000	usd
	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers	-110000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	82000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-150000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36336000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-26500000	usd
	nxdt	Distributions Paid In Cash DistributionsPaidInCash	-9714000	usd
	nxdt	Proceeds From Issuance Of Common Stock Excluding Subscriptions Receivable ProceedsFromIssuanceOfCommonStockExcludingSubscriptionsReceivable	1288000	usd
	nxdt	Proceeds From Dividend Reinvestment ProceedsFromDividendReinvestment	44000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-34970000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1366000	usd
	nxdt	Reinvestment Of Distributions ReinvestmentOfDistributions	1425000	usd
	nxdt	Interest Paid For Interest Expense And Commitment Fees InterestPaidForInterestExpenseAndCommitmentFees	614000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	245455000	usd
CY2021	nxdt	Proceeds From Return Of Capital Of Investment Securities From Affiliated Issues ProceedsFromReturnOfCapitalOfInvestmentSecuritiesFromAffiliatedIssues	52310000	usd
CY2021	nxdt	Payments For Purchase Of Securities Sold Short Operating Activities PaymentsForPurchaseOfSecuritiesSoldShortOperatingActivities	414000	usd
CY2021	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	490000	usd
CY2021	us-gaap	Realized Gain Loss Security Sold Short Operating RealizedGainLossSecuritySoldShortOperating	351000	usd
CY2021	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-202000	usd
CY2021	us-gaap	Increase Decrease In Client Funds Held IncreaseDecreaseInClientFundsHeld	192000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-743000	usd
CY2021	nxdt	Increase Decrease In Reclaim Receivable IncreaseDecreaseInReclaimReceivable	1250000	usd
CY2021	us-gaap	Increase Decrease In Payables To Broker Dealers IncreaseDecreaseInPayablesToBrokerDealers	-5687000	usd
CY2021	nxdt	Increase Decrease In Payable For Admin Fees IncreaseDecreaseInPayableForAdminFees	2000	usd
CY2021	nxdt	Audit Fees AuditFees	-391000	usd
CY2021	nxdt	Increase Decrease In Investment Advisory Fees IncreaseDecreaseInInvestmentAdvisoryFees	103000	usd
CY2021	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers	110000	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	60000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-7000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	38066000	usd
CY2021	nxdt	Proceeds Payments For Cumulative Preferred Shares ProceedsPaymentsForCumulativePreferredShares	83252000	usd
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-2500000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	20070000	usd
CY2021	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	105002000	usd
CY2021	nxdt	Proceeds From Issuance Of Common Stock Excluding Subscriptions Receivable ProceedsFromIssuanceOfCommonStockExcludingSubscriptionsReceivable	-72000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-44392000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6326000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9004000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2678000	usd
CY2021	nxdt	Reinvestment Of Distributions ReinvestmentOfDistributions	2131000	usd
CY2021	nxdt	Interest Paid For Interest Expense And Commitment Fees InterestPaidForInterestExpenseAndCommitmentFees	2371000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-114500000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-71600000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2900000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0238
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1393
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-24047000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-15036000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-27426000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.240
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-27258000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.381
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-648000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.006
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2247000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.031
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2731000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9975000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.139
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	137000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	2050000	usd
CY2023Q4	nxdt	Deferred Tax Assets Capital Loss Carryforwards Utilized DeferredTaxAssetsCapitalLossCarryforwardsUtilized	0	usd
CY2022Q4	nxdt	Deferred Tax Assets Capital Loss Carryforwards Utilized DeferredTaxAssetsCapitalLossCarryforwardsUtilized	1924000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	442000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	590000	usd
CY2023Q4	nxdt	Deferred Tax Assets Operating Loss Carryforwards Utilized DeferredTaxAssetsOperatingLossCarryforwardsUtilized	138000	usd
CY2022Q4	nxdt	Deferred Tax Assets Operating Loss Carryforwards Utilized DeferredTaxAssetsOperatingLossCarryforwardsUtilized	119000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	17351000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	16677000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17792000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17274000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14896000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15027000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2896000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2247000	usd
CY2022Q3	us-gaap	Land Land	21208000	usd
CY2022Q3	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	158304000	usd
CY2022Q3	us-gaap	Rental Properties RentalProperties	10979000	usd
CY2022Q3	us-gaap	Development In Process DevelopmentInProcess	46052000	usd
CY2022Q3	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	349000	usd
CY2022Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	236892000	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	804617000	usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	143264000	usd
CY2022Q3	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	56440000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16136000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	34640000	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	4849000	usd
CY2022Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	2816000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6375000	usd
CY2022Q3	us-gaap	Assets Assets	1306029000	usd
CY2022Q3	us-gaap	Loans Payable LoansPayable	145908000	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	23500000	usd
CY2022Q3	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	7492000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3322000	usd
	us-gaap	Depreciation Depreciation	4300000	usd
CY2023	nxdt	Net Amount Amortized As Increase To Rental Revenue For Capitalized Above And Below Market Lease NetAmountAmortizedAsIncreaseToRentalRevenueForCapitalizedAboveAndBelowMarketLease	-1200000	usd
	nxdt	Net Amount Amortized As Increase To Rental Revenue For Capitalized Above And Below Market Lease NetAmountAmortizedAsIncreaseToRentalRevenueForCapitalizedAboveAndBelowMarketLease	600000	usd
CY2022Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	2323000	usd
CY2022Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	639000	usd
CY2022Q3	us-gaap	Security Deposit Liability SecurityDepositLiability	434000	usd
CY2022Q3	us-gaap	Advance Rent AdvanceRent	1845000	usd
CY2022Q3	nxdt	Intangible Lease Liabilities Net IntangibleLeaseLiabilitiesNet	6770000	usd
CY2022Q3	nxdt	Due To Affiliates DueToAffiliates	928000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	193161000	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4800000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3359593	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3359593	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	3000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37171807	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37171807	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	37000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	999845000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	112983000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1112868000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1306029000	usd
CY2023Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	4	property
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	277669000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	18322000	usd
CY2023Q4	us-gaap	Sec Schedule Iii Real Estate Investment Property Net SECScheduleIIIRealEstateInvestmentPropertyNet	259347000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	266471000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	6415000	usd
CY2022Q4	us-gaap	Sec Schedule Iii Real Estate Investment Property Net SECScheduleIIIRealEstateInvestmentPropertyNet	260056000	usd
CY2023	us-gaap	Depreciation Depreciation	9400000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	24250000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturing In Years Four And Five LongTermDebtMaturingInYearsFourAndFive	1782000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	197337000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	66263000	usd
CY2023Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	38032000	usd
CY2023Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	28231000	usd
CY2023	nxdt	Equity Method Investment Share Of Earnings Loss EquityMethodInvestmentShareOfEarningsLoss	1570000	usd
CY2023Q4	nxdt	Equity Method Investments And Other Investments At Fair Value EquityMethodInvestmentsAndOtherInvestmentsAtFairValue	418134000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	70656000	usd
CY2022Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	49863000	usd
CY2022Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	20793000	usd
CY2022	nxdt	Equity Method Investment Share Of Earnings Loss EquityMethodInvestmentShareOfEarningsLoss	501000	usd
CY2022Q4	nxdt	Equity Method Investments And Other Investments At Fair Value EquityMethodInvestmentsAndOtherInvestmentsAtFairValue	526096000	usd
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	891924000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	914183000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts LifeSettlementContractsFairValueMethodNumberOfContracts	28	property
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Face Value LifeSettlementContractsFairValueMethodFaceValue	142952000	usd
CY2022Q4	nxdt	Life Settlement Contracts Fair Value Method Acquisition Cost LifeSettlementContractsFairValueMethodAcquisitionCost	48132000	usd
CY2022Q4	nxdt	Life Settlement Contracts Fair Value Method Premium Cost LifeSettlementContractsFairValueMethodPremiumCost	4589000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Carrying Amount LifeSettlementContractsFairValueMethodCarryingAmount	67711000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Next Rolling Twelve Months LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextRollingTwelveMonths	2	property
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Next Rolling Twelve Months LifeSettlementContractsFairValueMethodFaceValueMaturingInNextRollingTwelveMonths	7000000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Maturing In Next Rolling Twelve Months LifeSettlementContractsFairValueMaturingInNextRollingTwelveMonths	5950000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Two LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearTwo	2	property
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Two LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearTwo	7350000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Maturing In Rolling Year Two LifeSettlementContractsFairValueMaturingInRollingYearTwo	4774000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Three LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearThree	5	property
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Three LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearThree	19061000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Maturing In Rolling Year Three LifeSettlementContractsFairValueMaturingInRollingYearThree	11393000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Four LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearFour	8	property
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Four LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearFour	51351000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Maturing In Rolling Year Four LifeSettlementContractsFairValueMaturingInRollingYearFour	27648000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing In Rolling Year Five LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRollingYearFive	3	property
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing In Rolling Year Five LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearFive	17100000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Maturing In Rolling Year Five LifeSettlementContractsFairValueMaturingInRollingYearFive	7978000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts Maturing After Rolling Year Five LifeSettlementContractsFairValueMethodNumberOfContractsMaturingAfterRollingYearFive	8	property
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Face Value Maturing After Rolling Year Five LifeSettlementContractsFairValueMethodFaceValueMaturingAfterRollingYearFive	41090000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Maturing After Rolling Year Five LifeSettlementContractsFairValueMaturingAfterRollingYearFive	9968000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Number Of Contracts LifeSettlementContractsFairValueMethodNumberOfContracts	28	property
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Face Value LifeSettlementContractsFairValueMethodFaceValue	142952000	usd
CY2022Q4	us-gaap	Life Settlement Contracts Fair Value Method Carrying Amount LifeSettlementContractsFairValueMethodCarryingAmount	67711000	usd
	nxdt	Life Insurance Policies Purchased Number LifeInsurancePoliciesPurchasedNumber	3	property
	nxdt	Life Insurance Policies Purchased Face Value LifeInsurancePoliciesPurchasedFaceValue	28000000	usd
	nxdt	Life Insurance Policies Purchased Payment LifeInsurancePoliciesPurchasedPayment	8700000	usd
	nxdt	Life Insurance Policies Matured Number LifeInsurancePoliciesMaturedNumber	1	property
	nxdt	Life Insurance Policies Matured Net Death Benefit LifeInsurancePoliciesMaturedNetDeathBenefit	7000000	usd
	nxdt	Life Insurance Policies Matured Premiums LifeInsurancePoliciesMaturedPremiums	2600000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38389600	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023	nxdt	Stock Issued During Period Shares Pursuant To Dividend Reimbursement Plan That Was Terminated StockIssuedDuringPeriodSharesPursuantToDividendReimbursementPlanThatWasTerminated	1217792.99	shares
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2023Q3	nxdt	Percentage Of Common Stock Dividend Paid As Cash PercentageOfCommonStockDividendPaidAsCash	0.20
	nxdt	Stock Issued During Period Shares Pursuant To Dividend Reimbursement Plan That Was Terminated StockIssuedDuringPeriodSharesPursuantToDividendReimbursementPlanThatWasTerminated	92067	shares
	nxdt	Stock Issued During Period Shares Pursuant To Dividend Reimbursement Plan That Was Terminated StockIssuedDuringPeriodSharesPursuantToDividendReimbursementPlanThatWasTerminated	0	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37171807	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-121860000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-83883000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37172000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37334000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37172000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.26
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.26
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	439601	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023	nxdt	Annual Advisory Fee Percent AnnualAdvisoryFeePercent	0.0100
CY2023	nxdt	Administrative Fee Percent AdministrativeFeePercent	0.0020
CY2023	nxdt	Annual Advisory Fee Percent AnnualAdvisoryFeePercent	0.0100
CY2023	nxdt	Administrative Fee Percent AdministrativeFeePercent	0.0020
CY2023Q2	nxdt	Advisory Agreement Maximum Common Shares Issuable AdvisoryAgreementMaximumCommonSharesIssuable	6000000	shares
CY2023	nxdt	Maximum Fee Percentage Of Managed Assets MaximumFeePercentageOfManagedAssets	0.015
CY2023	nxdt	Advisory Agreement Term AdvisoryAgreementTerm	P3Y
CY2023	nxdt	Advisory Agreement Additional Term AdvisoryAgreementAdditionalTerm	P1Y
CY2023	nxdt	Advisory Agreement Termination Threshold With Cause AdvisoryAgreementTerminationThresholdWithCause	P30D
CY2023	nxdt	Advisory Agreement Termination Threshold Without Cause AdvisoryAgreementTerminationThresholdWithoutCause	P180D
CY2023	nxdt	Advisory Agreement Termination Threshold Material Breach Of Contract AdvisoryAgreementTerminationThresholdMaterialBreachOfContract	P30D
CY2023	nxdt	Advisory Agreement Material Breach Of Contract Term AdvisoryAgreementMaterialBreachOfContractTerm	P30D
CY2023Q4	nxdt	Advisory Agreement Automatic Termination Termination Fee Fees Earned Multiplier AdvisoryAgreementAutomaticTerminationTerminationFeeFeesEarnedMultiplier	3
CY2023	nxdt	Termination Fee Calculation Threshold Period TerminationFeeCalculationThresholdPeriod	P1Y
CY2023	nxdt	Administrative And Advisory Fees Expense AdministrativeAndAdvisoryFeesExpense	13700000	usd
CY2023	nxdt	Administrative And Advisory Fees Expense Waived To Comply With Cap AdministrativeAndAdvisoryFeesExpenseWaivedToComplyWithCap	2000000	usd
CY2022Q4	nxdt	Noncontrolling Interest Shares Redeemed NoncontrollingInterestSharesRedeemed	2100000	shares
CY2022Q4	nxdt	Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests	2100000	shares
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	9672000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9256000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7931000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7097000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5513000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	22718000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	62187000	usd

Files In Submission

Name	View Source	Status
0001356115-24-000007-index-headers.html	Edgar Link	pending
0001356115-24-000007-index.html	Edgar Link	pending
0001356115-24-000007.txt	Edgar Link	pending
0001356115-24-000007-xbrl.zip	Edgar Link	pending
a105-formofrsuagreementtru.htm	Edgar Link	pending
a106-formofrsuagreementkey.htm	Edgar Link	pending
a211nxdt-ex211listofsubsid.htm	Edgar Link	pending
cohenlogo2a.jpg	Edgar Link	pending
cohenlogo3a.jpg	Edgar Link	pending
cohenlogoa.jpg	Edgar Link	pending
ex10_34.htm	Edgar Link	pending
ex10_34.pdf	Edgar Link	pending
ex10_34001.jpg	Edgar Link	pending
ex10_34002.jpg	Edgar Link	pending
ex10_34003.jpg	Edgar Link	pending
ex10_34004.jpg	Edgar Link	pending
ex10_34005.jpg	Edgar Link	pending
ex10_34006.jpg	Edgar Link	pending
ex10_34007.jpg	Edgar Link	pending
ex10_34008.jpg	Edgar Link	pending
ex10_34009.jpg	Edgar Link	pending
ex10_34010.jpg	Edgar Link	pending
ex10_34011.jpg	Edgar Link	pending
ex10_34012.jpg	Edgar Link	pending
ex10_34013.jpg	Edgar Link	pending
ex10_34014.jpg	Edgar Link	pending
ex10_34015.jpg	Edgar Link	pending
ex10_34016.jpg	Edgar Link	pending
ex10_34017.jpg	Edgar Link	pending
ex10_35.htm	Edgar Link	pending
ex10_35.pdf	Edgar Link	pending
ex10_35001.jpg	Edgar Link	pending
ex10_35002.jpg	Edgar Link	pending
ex10_35003.jpg	Edgar Link	pending
ex10_35004.jpg	Edgar Link	pending
ex10_36.htm	Edgar Link	pending
ex10_36.pdf	Edgar Link	pending
ex10_36001.jpg	Edgar Link	pending
ex10_36002.jpg	Edgar Link	pending
ex10_36003.jpg	Edgar Link	pending
ex10_36004.jpg	Edgar Link	pending
ex10_37.htm	Edgar Link	pending
ex10_37.pdf	Edgar Link	pending
ex10_37001.jpg	Edgar Link	pending
ex10_37002.jpg	Edgar Link	pending
ex10_37003.jpg	Edgar Link	pending
ex10_37004.jpg	Edgar Link	pending
ex10_37005.jpg	Edgar Link	pending
ex10_37006.jpg	Edgar Link	pending
ex10_37007.jpg	Edgar Link	pending
ex10_37008.jpg	Edgar Link	pending
ex10_37009.jpg	Edgar Link	pending
ex10_37010.jpg	Edgar Link	pending
ex10_37011.jpg	Edgar Link	pending
ex10_37012.jpg	Edgar Link	pending
ex10_37013.jpg	Edgar Link	pending
ex10_37014.jpg	Edgar Link	pending
ex10_37015.jpg	Edgar Link	pending
ex10_37016.jpg	Edgar Link	pending
ex10_37017.jpg	Edgar Link	pending
ex10_38.htm	Edgar Link	pending
ex10_38.pdf	Edgar Link	pending
ex10_38001.jpg	Edgar Link	pending
ex10_38002.jpg	Edgar Link	pending
ex10_38003.jpg	Edgar Link	pending
ex10_39.htm	Edgar Link	pending
ex10_39.pdf	Edgar Link	pending
ex10_39001.jpg	Edgar Link	pending
ex10_39002.jpg	Edgar Link	pending
ex10_39003.jpg	Edgar Link	pending
ex10_39004.jpg	Edgar Link	pending
ex10_40.htm	Edgar Link	pending
ex10_40.pdf	Edgar Link	pending
ex10_40001.jpg	Edgar Link	pending
ex10_40002.jpg	Edgar Link	pending
ex10_40003.jpg	Edgar Link	pending
ex10_40004.jpg	Edgar Link	pending
ex10_40005.jpg	Edgar Link	pending
ex10_40006.jpg	Edgar Link	pending
ex10_40007.jpg	Edgar Link	pending
ex10_40008.jpg	Edgar Link	pending
ex10_40009.jpg	Edgar Link	pending
ex10_40010.jpg	Edgar Link	pending
ex10_40011.jpg	Edgar Link	pending
ex10_41.htm	Edgar Link	pending
ex10_41.pdf	Edgar Link	pending
ex10_41001.jpg	Edgar Link	pending
ex10_41002.jpg	Edgar Link	pending
ex10_41003.jpg	Edgar Link	pending
ex10_41004.jpg	Edgar Link	pending
ex10_42.htm	Edgar Link	pending
ex10_42.pdf	Edgar Link	pending
ex10_42001.jpg	Edgar Link	pending
ex10_42002.jpg	Edgar Link	pending
ex10_42003.jpg	Edgar Link	pending
ex10_42004.jpg	Edgar Link	pending
ex10_42005.jpg	Edgar Link	pending
ex10_42006.jpg	Edgar Link	pending
ex10_42007.jpg	Edgar Link	pending
ex10_42008.jpg	Edgar Link	pending
ex10_42009.jpg	Edgar Link	pending
ex10_42010.jpg	Edgar Link	pending
ex10_43.htm	Edgar Link	pending
ex10_43001.jpg	Edgar Link	pending
ex10_43002.jpg	Edgar Link	pending
ex10_43003.jpg	Edgar Link	pending
ex10_43004.jpg	Edgar Link	pending
ex10_43005.jpg	Edgar Link	pending
ex10_43006.jpg	Edgar Link	pending
ex10_43007.jpg	Edgar Link	pending
ex10_43008.jpg	Edgar Link	pending
ex10_43009.jpg	Edgar Link	pending
ex10_43010.jpg	Edgar Link	pending
ex10_43011.jpg	Edgar Link	pending
ex10_43012.jpg	Edgar Link	pending
ex10_43013.jpg	Edgar Link	pending
ex10_43014.jpg	Edgar Link	pending
ex10_44.htm	Edgar Link	pending
ex10_44.pdf	Edgar Link	pending
ex10_44001.jpg	Edgar Link	pending
ex10_44002.jpg	Edgar Link	pending
ex10_44003.jpg	Edgar Link	pending
ex10_44004.jpg	Edgar Link	pending
ex10_44005.jpg	Edgar Link	pending
ex10_44006.jpg	Edgar Link	pending
ex10_44007.jpg	Edgar Link	pending
ex10_44008.jpg	Edgar Link	pending
ex10_44009.jpg	Edgar Link	pending
ex10_44010.jpg	Edgar Link	pending
ex10_44011.jpg	Edgar Link	pending
ex10_44012.jpg	Edgar Link	pending
ex10_44013.jpg	Edgar Link	pending
ex10_45.htm	Edgar Link	pending
ex10_45.pdf	Edgar Link	pending
ex10_45001.jpg	Edgar Link	pending
ex10_45002.jpg	Edgar Link	pending
ex10_45003.jpg	Edgar Link	pending
ex10_45004.jpg	Edgar Link	pending
ex10_45005.jpg	Edgar Link	pending
ex10_45006.jpg	Edgar Link	pending
ex10_45007.jpg	Edgar Link	pending
ex10_45008.jpg	Edgar Link	pending
ex10_45009.jpg	Edgar Link	pending
ex10_45010.jpg	Edgar Link	pending
ex10_45011.jpg	Edgar Link	pending
ex10_45012.jpg	Edgar Link	pending
ex10_45013.jpg	Edgar Link	pending
ex10_45014.jpg	Edgar Link	pending
ex10_45015.jpg	Edgar Link	pending
ex10_46.htm	Edgar Link	pending
ex10_46.pdf	Edgar Link	pending
ex10_46001.jpg	Edgar Link	pending
ex10_46002.jpg	Edgar Link	pending
ex10_46003.jpg	Edgar Link	pending
ex10_46004.jpg	Edgar Link	pending
ex10_46005.jpg	Edgar Link	pending
ex10_46006.jpg	Edgar Link	pending
ex10_46007.jpg	Edgar Link	pending
ex10_46008.jpg	Edgar Link	pending
ex10_46009.jpg	Edgar Link	pending
ex10_46010.jpg	Edgar Link	pending
ex10_46011.jpg	Edgar Link	pending
ex10_46012.jpg	Edgar Link	pending
ex10_46013.jpg	Edgar Link	pending
ex10_47.htm	Edgar Link	pending
ex10_47.pdf	Edgar Link	pending
ex10_47001.jpg	Edgar Link	pending
ex10_47002.jpg	Edgar Link	pending
ex10_47003.jpg	Edgar Link	pending
ex10_47004.jpg	Edgar Link	pending
ex10_47005.jpg	Edgar Link	pending
ex10_47006.jpg	Edgar Link	pending
ex10_47007.jpg	Edgar Link	pending
ex10_47008.jpg	Edgar Link	pending
ex10_47009.jpg	Edgar Link	pending
ex10_47010.jpg	Edgar Link	pending
ex10_47011.jpg	Edgar Link	pending
ex10_47012.jpg	Edgar Link	pending
ex10_47013.jpg	Edgar Link	pending
ex10_47014.jpg	Edgar Link	pending
ex10_47015.jpg	Edgar Link	pending
ex10_47016.jpg	Edgar Link	pending
ex10_47017.jpg	Edgar Link	pending
ex10_47018.jpg	Edgar Link	pending
ex10_47019.jpg	Edgar Link	pending
ex10_47020.jpg	Edgar Link	pending
ex10_47021.jpg	Edgar Link	pending
ex10_47022.jpg	Edgar Link	pending
ex10_47023.jpg	Edgar Link	pending
ex10_47024.jpg	Edgar Link	pending
ex10_47025.jpg	Edgar Link	pending
ex10_47026.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_3a.jpg	Edgar Link	pending
kpmg_0.jpg	Edgar Link	pending
kpmg_2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nxdt-20231231.htm	Edgar Link	pending
nxdt-20231231.xsd	Edgar Link	pending
nxdt-20231231xexx311.htm	Edgar Link	pending
nxdt-20231231xexx312.htm	Edgar Link	pending
nxdt-20231231xexx321.htm	Edgar Link	pending
nxdt-20231231_g1.gif	Edgar Link	pending
nxdt-20231231_g2.jpg	Edgar Link	pending
nxdt-20231231_g3.jpg	Edgar Link	pending
nxdt-20231231_g4.jpg	Edgar Link	pending
nxdt-formofrsuawardagreeme.htm	Edgar Link	pending
nxdt-formofrsuawardagreemea.htm	Edgar Link	pending
nxdt-xinsidertradingpolicy.htm	Edgar Link	pending
nxdt12312023_consentforfsi.htm	Edgar Link	pending
nxdt2023consent_2024031222.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
nxdt-20231231_lab.xml	Edgar Link	unprocessable
nxdt-20231231_pre.xml	Edgar Link	unprocessable
nxdt-20231231_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nxdt-20231231_cal.xml	Edgar Link	unprocessable
nxdt-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NXDT
NEXPOINT DIVERSIFIED REAL ESTATE TRUST Stock $nxdt

2024 Q1 Form 10-K Financial Statement

#000135611524000007 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXDT NEXPOINT DIVERSIFIED REAL ESTATE TRUST Stock $nxdt

2024 Q1 Form 10-K Financial Statement

#000135611524000007 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXDT
NEXPOINT DIVERSIFIED REAL ESTATE TRUST Stock $nxdt